文献速递心力衰竭与心肌病

血浆蛋白质组学预测肥厚型心肌病心力衰竭恶化

Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics.
PubMed 文献 · Heart · 2023-11-27

这项多中心前瞻性队列研究纳入389例肥厚型心肌病患者,基线进行4986种血浆蛋白的蛋白质组学分析,用其中一家机构的268例数据训练随机森林模型,在另一家机构的121例中外部验证。基于11种蛋白的模型在测试集中预测心力衰竭恶化的AUC为0.87(95%CI:0.76至0.98),通路分析显示Ras-MAPK通路(FDR<0.00001)及相关通路在后续发生心力衰竭恶化的患者中失调。

要点

  • 基于11种血浆蛋白的模型在外部验证集中预测HCM患者心力衰竭恶化的AUC达0.87。
  • Ras-MAPK通路(FDR<0.00001)及相关通路在后续发生心力衰竭恶化的患者中失调。
  • 血浆蛋白质组学有助于识别HCM中心力衰竭恶化高风险患者并揭示潜在机制。

核心结论

  • 基于血浆蛋白质组学的11蛋白模型在肥厚型心肌病患者中预测心力衰竭恶化具有较高准确性。
  • Ras-MAPK及相关信号通路可能是肥厚型心肌病患者发生心力衰竭恶化的潜在机制。

研究设计与样本

  • 多中心前瞻性队列研究,纳入389例肥厚型心肌病患者,基线进行4986种血浆蛋白的蛋白质组学分析。
  • 使用一家机构的268例患者作为训练集构建蛋白质组学随机森林模型,在另一家机构的121例患者中外部验证。

主要发现

  • 基于训练集得出的11蛋白蛋白质组学模型在测试集中预测心力衰竭恶化的AUC为0.87(95%CI:0.76至0.98)。
  • 通路分析显示Ras-MAPK通路(FDR<0.00001)及相关通路在后续发生心力衰竭恶化的患者中失调。

关键数值与推荐

  • 通路分析采用错误发现率(FDR)阈值<0.001。
  • Ras-MAPK通路的FDR<0.00001。

临床怎么用

  • 血浆蛋白质组学模型可能辅助识别肥厚型心肌病中心力衰竭恶化高风险患者。
  • Ras-MAPK及相关通路可能作为未来干预的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Heart failure (HF) is one of the most common and lifestyle-limiting complications of hypertrophic cardiomyopathy (HCM). Prediction of worsening HF using clinical measures alone remains limited. Moreover, the mechanisms by which patients with HCM develop worsening HF have not been elucidated. Therefore, the aim of this study was to develop a plasma proteomics-based model to predict worsening HF among patients with HCM and to identify signalling pathways that are differentially regulated in those who subsequently develop worsening HF. METHODS: In this multi-centre, prospective cohort study of 389 patients with HCM, plasma proteomics profiling of 4986 proteins was performed at enrolment. A proteomics-based random forest model was developed to predict worsening HF using data from one institution (training set, n=268). This model was externally validated in patients from a different institution (test set, n=121). Pathway analysis of proteins significantly dysregulated in patients who subsequently developed worsening HF compared with those who did not was executed, using a false discovery rate (FDR) threshold of <0.001. RESULTS: Using the 11-protein proteomics-based model derived from the training set, the area under the receiver-operating characteristic curve to predict worsening HF was 0.87 (95% CI: 0.76 to 0.98) in the test set. Pathway analysis revealed that the Ras-MAPK pathway (FDR<0.00001) and related pathways were dysregulated in patients who subsequently developed worsening HF. CONCLUSIONS: The present study with comprehensive plasma proteomics profiling demonstrated a high accuracy to predict worsening HF in patients with HCM and identified the Ras-MAPK and related signalling pathways as potential underlying mechanisms.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Lumish, Liang, Hasegawa, et al. Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics. Heart. 2023. PMID: 37451849. doi:10.1136/heartjnl-2023-322644

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。